InvestorsObserver
×
News Home

Should You Buy Lixte Biotechnology Holdings Inc (LIXT) Stock Monday Morning?

Monday, April 01, 2024 06:51 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Lixte Biotechnology Holdings Inc (LIXT) Stock Monday Morning?

Lixte Biotechnology Holdings Inc (LIXT) is down -11.24%% today.

Overall Score - 14
LIXT has an Overall Score of 14. Find out what this means to you and get the rest of the rankings on LIXT!
LIXT stock closed at $3.38 and is down -$0.38 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. LIXT has a poor overall score of 14 meaning the stock holds a better value than just 14% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. LIXT gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. Lixte Biotechnology Holdings Inc currently has the 92th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders.
Lixte Biotechnology Holdings Inc's Overall and Short-Term Technical score paint a mixed picture for LIXT's recent trading patterns and forecasted price. Click Here To Get The Full Report on Lixte Biotechnology Holdings Inc (LIXT)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App